Literature DB >> 18021921

Novel mutation confirms seizure locus SCN1A is also familial hemiplegic migraine locus FHM3.

J Jay Gargus1, Anne Tournay.   

Abstract

Although SCN1A, the gene encoding the neuronal voltage-gated sodium channel, type 1A, is a well-recognized target of mutations underlying a spectrum of epilepsy syndromes, and lies within an extended 12-Mb disease-associated haplotype at the familial hemiplegic migraine-3 locus, it remains to be confirmed that mutations within this gene itself cause syndromes that include migraine phenotypes. The novel T1174S missense mutation of this gene was detected segregating in a family with a heterozygous female child who presented with myoclonus and an abnormal electroencephalogram, and in her heterozygous mother, who had an ataxic migraine syndrome similar to that of her own mother. This three-generation family exhibits the broad phenotypic spectrum of the dominant neuronal hyperexcitability syndromes produced by even a given allele of this sodium channel gene. It also exhibits the second allele of this sodium channel gene associated with a migraine syndrome similar to those caused at the two other familial hemiplegic migraine loci, confirming that this gene itself, not some linked gene, is the familial hemiplegic migraine-3 locus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18021921      PMCID: PMC2151385          DOI: 10.1016/j.pediatrneurol.2007.06.016

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  18 in total

1.  Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2.

Authors:  A Escayg; B T MacDonald; M H Meisler; S Baulac; G Huberfeld; I An-Gourfinkel; A Brice; E LeGuern; B Moulard; D Chaigne; C Buresi; A Malafosse
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

2.  Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy.

Authors:  T Sugawara; E Mazaki-Miyazaki; K Fukushima; J Shimomura; T Fujiwara; S Hamano; Y Inoue; K Yamakawa
Journal:  Neurology       Date:  2002-04-09       Impact factor: 9.910

Review 3.  Unraveling monogenic channelopathies and their implications for complex polygenic disease.

Authors:  J Jay Gargus
Journal:  Am J Hum Genet       Date:  2003-03-07       Impact factor: 11.025

4.  Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness.

Authors:  S Kaja; R C G van de Ven; L A M Broos; H Veldman; J G van Dijk; J J G M Verschuuren; R R Frants; M D Ferrari; A M J M van den Maagdenberg; J J Plomp
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

5.  Alterations in the alpha2 isoform of Na,K-ATPase associated with familial hemiplegic migraine type 2.

Authors:  Laura Segall; Alessandra Mezzetti; Rosemarie Scanzano; J Jay Gargus; Enrico Purisima; Rhoda Blostein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-21       Impact factor: 11.205

6.  [ATP1A2: a key player in familial hemiplegic migraine].

Authors:  Rhoda Blostein; Laura Segall; J Jay Gargus
Journal:  Med Sci (Paris)       Date:  2006-04       Impact factor: 0.818

7.  Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel.

Authors:  A Jouvenceau; L H Eunson; A Spauschus; V Ramesh; S M Zuberi; D M Kullmann; M G Hanna
Journal:  Lancet       Date:  2001-09-08       Impact factor: 79.321

8.  Sodium channels SCN1A, SCN2A and SCN3A in familial autism.

Authors:  L A Weiss; A Escayg; J A Kearney; M Trudeau; B T MacDonald; M Mori; J Reichert; J D Buxbaum; M H Meisler
Journal:  Mol Psychiatry       Date:  2003-02       Impact factor: 15.992

Review 9.  Ion channel functional candidate genes in multigenic neuropsychiatric disease.

Authors:  J Jay Gargus
Journal:  Biol Psychiatry       Date:  2006-02-21       Impact factor: 13.382

10.  Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2.

Authors:  Maurizio De Fusco; Roberto Marconi; Laura Silvestri; Luigia Atorino; Luca Rampoldi; Letterio Morgante; Andrea Ballabio; Paolo Aridon; Giorgio Casari
Journal:  Nat Genet       Date:  2003-01-21       Impact factor: 38.330

View more
  15 in total

Review 1.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

Review 2.  The physiological function of different voltage-gated sodium channels in pain.

Authors:  George Goodwin; Stephen B McMahon
Journal:  Nat Rev Neurosci       Date:  2021-03-29       Impact factor: 34.870

3.  Pharmacology of the Nav1.1 domain IV voltage sensor reveals coupling between inactivation gating processes.

Authors:  Jeremiah D Osteen; Kevin Sampson; Vivek Iyer; David Julius; Frank Bosmans
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

4.  Migraine genetics: current findings and future lines of research.

Authors:  A M Persico; M Verdecchia; V Pinzone; V Guidetti
Journal:  Neurogenetics       Date:  2014-12-14       Impact factor: 2.660

5.  Self-limited hyperexcitability: functional effect of a familial hemiplegic migraine mutation of the Nav1.1 (SCN1A) Na+ channel.

Authors:  Sandrine Cestèle; Paolo Scalmani; Raffaella Rusconi; Benedetta Terragni; Silvana Franceschetti; Massimo Mantegazza
Journal:  J Neurosci       Date:  2008-07-16       Impact factor: 6.167

6.  Familial hemiplegic migraine: linkage to chromosome 14q32 in a Spanish kindred.

Authors:  Ester Cuenca-León; Roser Corominas; Magda Montfort; Josep Artigas; Manuel Roig; Mònica Bayés; Bru Cormand; Alfons Macaya
Journal:  Neurogenetics       Date:  2009-01-20       Impact factor: 2.660

Review 7.  Sodium channelopathies and pain.

Authors:  Angelika Lampert; Andrias O O'Reilly; Peter Reeh; Andreas Leffler
Journal:  Pflugers Arch       Date:  2010-01-26       Impact factor: 3.657

Review 8.  Epilepsy and Migraine Shared Genetic and Molecular Mechanisms: Focus on Therapeutic Strategies.

Authors:  Palvi Gotra; Nidhi Bhardwaj; Abhilash Ludhiadch; Gagandeep Singh; Anjana Munshi
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

Review 9.  Sodium channelopathies of skeletal muscle and brain.

Authors:  Massimo Mantegazza; Sandrine Cestèle; William A Catterall
Journal:  Physiol Rev       Date:  2021-03-26       Impact factor: 46.500

Review 10.  Channelopathy pathogenesis in autism spectrum disorders.

Authors:  Galina Schmunk; J Jay Gargus
Journal:  Front Genet       Date:  2013-11-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.